Apple stock breaks past a 228.62 buy point, accelerating earnings and revenue growth with a 97 IBD Composite Rating.
Apple Inc. shares surged to a record $292.84, clearing a five-month consolidation pattern at a 228.62 buy point. The move reflects accelerating earnings and revenue growth, per IBD analysis.
The stock’s Relative Strength line, previously lackluster, has shown recent improvement. Apple holds a 97/99 IBD Composite Rating and ranks 53rd among 197 industry groups. The breakout follows a sideways consolidation pattern, deviating from traditional base definitions.
No immediate market reaction details were provided, but the stock’s upward momentum aligns with pre-WWDC sentiment.